ALKERMES PLC's ticker is ALKS and the CUSIP is G01767105. A total of 267 filers reported holding ALKERMES PLC in Q4 2016. The put-call ratio across all filers is 0.37 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2018 | $13,804,000 | +2.6% | 325,266 | -0.5% | 0.22% | +0.9% |
| Q2 2018 | $13,453,000 | -30.3% | 326,855 | -1.9% | 0.22% | -32.5% |
| Q1 2018 | $19,313,000 | +15.1% | 333,219 | +8.7% | 0.33% | +13.6% |
| Q4 2017 | $16,784,000 | +7.0% | 306,678 | -0.6% | 0.29% | +9.5% |
| Q3 2017 | $15,686,000 | -12.3% | 308,531 | +0.0% | 0.26% | -15.2% |
| Q2 2017 | $17,878,000 | +23.0% | 308,396 | +24.1% | 0.31% | +12.8% |
| Q1 2017 | $14,535,000 | +0.5% | 248,469 | -4.5% | 0.27% | -2.8% |
| Q4 2016 | $14,466,000 | +9.4% | 260,268 | -7.4% | 0.28% | +13.7% |
| Q3 2016 | $13,220,000 | +37.0% | 281,098 | +25.9% | 0.25% | +24.6% |
| Q2 2016 | $9,650,000 | +47.8% | 223,274 | +16.9% | 0.20% | +37.2% |
| Q1 2016 | $6,529,000 | -23.5% | 190,974 | +77.6% | 0.14% | -27.5% |
| Q4 2015 | $8,538,000 | +37.0% | 107,558 | +1.2% | 0.20% | +34.2% |
| Q3 2015 | $6,234,000 | +44.4% | 106,253 | +58.3% | 0.15% | +52.0% |
| Q2 2015 | $4,318,000 | – | 67,117 | – | 0.10% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Woodford Investment Management Ltd | 2,639,676 | $96,322,000 | 7.78% |
| Meditor Group Ltd | 892,400 | $32,564,000 | 6.11% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 233,000 | $8,502,000 | 3.14% |
| Tamarack Advisers, LP | 140,000 | $5,109,000 | 2.03% |
| Asymmetry Capital Management, L.P. | 27,673 | $1,010,000 | 1.69% |
| First Light Asset Management, LLC | 211,164 | $7,705,000 | 1.00% |
| BOGLE INVESTMENT MANAGEMENT L P /DE/ | 304,992 | $11,129,000 | 0.85% |
| Nicollet Investment Management, Inc. | 28,020 | $1,022,000 | 0.67% |
| PRIMECAP MANAGEMENT CO/CA/ | 23,263,530 | $848,886,000 | 0.62% |
| Rhenman & Partners Asset Management AB | 120,399 | $4,393,000 | 0.51% |